<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.36">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>talks - Esophageal Cancer and Sarcopenia</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">talks</span>
  </a>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html">Home</a>
  </li>  
  <li class="dropdown-header">
 about.qmd</li>
</ul>
              <div id="quarto-search" class="" title="Search"></div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#sarcopenia-in-esophageal-cancer" id="toc-sarcopenia-in-esophageal-cancer" class="nav-link active" data-scroll-target="#sarcopenia-in-esophageal-cancer">Sarcopenia in esophageal cancer</a>
  <ul class="collapse">
  <li><a href="#skeletal-muscle-loss-in-esophagectomy-patients" id="toc-skeletal-muscle-loss-in-esophagectomy-patients" class="nav-link" data-scroll-target="#skeletal-muscle-loss-in-esophagectomy-patients">Skeletal muscle loss in esophagectomy patients</a></li>
  <li><a href="#skeletal-muscle-loss-during-esophageal-chemort" id="toc-skeletal-muscle-loss-during-esophageal-chemort" class="nav-link" data-scroll-target="#skeletal-muscle-loss-during-esophageal-chemort">Skeletal Muscle Loss during Esophageal ChemoRT</a></li>
  <li><a href="#skeletal-muscle-loss-during-chemotherapy" id="toc-skeletal-muscle-loss-during-chemotherapy" class="nav-link" data-scroll-target="#skeletal-muscle-loss-during-chemotherapy">Skeletal muscle loss during chemotherapy</a></li>
  <li><a href="#skeletal-muscle-loss-and-survival-after-esophagectomy" id="toc-skeletal-muscle-loss-and-survival-after-esophagectomy" class="nav-link" data-scroll-target="#skeletal-muscle-loss-and-survival-after-esophagectomy">Skeletal muscle loss and survival after esophagectomy</a></li>
  </ul></li>
  <li><a href="#risk-stratification-for-esophagectomy" id="toc-risk-stratification-for-esophagectomy" class="nav-link" data-scroll-target="#risk-stratification-for-esophagectomy">Risk Stratification for esophagectomy</a>
  <ul class="collapse">
  <li><a href="#v02max" id="toc-v02max" class="nav-link" data-scroll-target="#v02max">V02max</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Esophageal Cancer and Sarcopenia</h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<section id="sarcopenia-in-esophageal-cancer" class="level1">
<h1>Sarcopenia in esophageal cancer</h1>
<p><a href="sarcopenia_lit.html">Sarcopenia Methods</a> <a href="gi_sarcopenia_lit.html">Sarcopenia in GI Cancers</a> <a href="chemo_sarcopenia_lit.html">Sarcopenia in Chemotherapy</a> <a href="es_cancertx_lit.html">Esophageal Cancer Therapy</a></p>
<p>The patient with esophageal cancer faces multiple challenges in changes in body composition related to both muscle mass and adipose tissue. Patients frequently present with loss of adipose tissue and muscle from dysphaghia due to the primary tumor. Neoadjuvant chemoradiation can improve oral intake due to tumor shrinkage, but can also decrease oral nutrition due to esophagitis and the catabolic effects of cytotoxic therapy.&nbsp; In addition, patients undergoing esophagectomy frequently lose weight due to limited oral intake and the catabolic effects of the stress of surgery.</p>
<p>For patients treated with neoadjuvant therapy, the chemoradiation treatment prior to surgery can be seen as a ‘stress test’ which can further assist in evaluating a patient’s resilience to the stress of surgery.</p>
<p>The coexistence of sarcopenia and obesity has led to the identification of a syndrome of sarcopenia obesity, defined as sarcopenia in the context of a BMI &gt;30kg/m^2. These patients suffer the consequences of both loss of muscle mass with excess adipose tissue, which appear to act synergistically to decrease survival in cancer patients.<span class="citation" data-cites="prado629">(<a href="#ref-prado629" role="doc-biblioref"><strong>prado629?</strong></a>)</span> <span class="citation" data-cites="martin">(<a href="#ref-martin" role="doc-biblioref"><strong>martin?</strong></a>)</span></p>
<section id="skeletal-muscle-loss-in-esophagectomy-patients" class="level2">
<h2 class="anchored" data-anchor-id="skeletal-muscle-loss-in-esophagectomy-patients">Skeletal muscle loss in esophagectomy patients</h2>
<p>A Japanese group of 190 patients undergoing esophagectomy were studied. Sarcopenia was found in 149 (75%).[<span class="citation" data-cites="nishigori">(<a href="#ref-nishigori" role="doc-biblioref"><strong>nishigori?</strong></a>)</span>]{Nishigori, 2016 #1996} Among sarcopenic patients, pneumonia occurred in 44 (29%) vs 5 (10%) among patients without sarcopenia. Another group<span class="citation" data-cites="Ida">(<a href="#ref-Ida" role="doc-biblioref"><strong>Ida?</strong></a>)</span> {Ida, 2015 #1995} found similar association between sarcopenia and pulmonary complications after esophagectomy.</p>
<p>A Japanese study examined the predictive value of sarcopenia relative to anastomotic after esophagectomy<span class="citation" data-cites="tamandl1359">(<a href="#ref-tamandl1359" role="doc-biblioref">Tamandl et al. 2016</a>)</span>. While sarcopenia in patients under age 65 was not associated with adverse outcomes, among 166 patients over age 65, sarcopenia was associated with increased risk of anastomotic leak and in-hospital mortality.</p>
<p>Among 98 Japanese patients undergoing esophagectomy for esophageal cancer, 31 (31%) were found to be sarcopenic. Among these patients the 90-day readmission rate was 42.9% vs 16% in those without sarcopenia<span class="citation" data-cites="makiura456">(<a href="#ref-makiura456" role="doc-biblioref"><strong>makiura456?</strong></a>)</span>. In addition, sarcopenia was associated with overall survival after adjusting for age, gender, and pathologic stage.</p>
<p>Irish study <span class="citation" data-cites="elliott822">(<a href="#ref-elliott822" role="doc-biblioref">Elliott et al. 2017</a>)</span></p>
</section>
<section id="skeletal-muscle-loss-during-esophageal-chemort" class="level2">
<h2 class="anchored" data-anchor-id="skeletal-muscle-loss-during-esophageal-chemort">Skeletal Muscle Loss during Esophageal ChemoRT</h2>
<p>Nottingham: 89 patients with esophageal cancer undergoing neoadjuvant chemotherapy. Sarcopenia associated with dose-limiting toxiciy and shortened survival after esopahgectomy <span class="citation" data-cites="tan333">(<a href="#ref-tan333" role="doc-biblioref">Tan et al. 2015</a>)</span></p>
<p>72 pts getting neoadjuvant chemotherapy. Sarcopenic obesity associated with dose-limiting toxicity.<span class="citation" data-cites="anandavadivelan724">(<a href="#ref-anandavadivelan724" role="doc-biblioref"><strong>anandavadivelan724?</strong></a>)</span></p>
<p>47 patients getting neoadjuvant chemotherapy . Chemotherapy increased rate of sarcopenia. <span class="citation" data-cites="awad74">(<a href="#ref-awad74" role="doc-biblioref">Awad et al. 2012</a>)</span></p>
<p>A small group of patients (n=35) with esophageal cancer undergoing neoadjuvant chemoradiation showed an increase in the percentage rated as sarcopenic as a result of chemoradiation {Yip, 2014 #2001}. Investigators in the UK noted similar changes in muscle mass among 14 patients as a result of neoadjuvant chemotherapy{Awad, 2012 #1990}. Neither study showed differences between loss of muscle mass and length of stay or survival, although neither study included a power analysis of these outcomes. A larger study from the Netherlands (n=123) {Reisinger, 2015 #1993} showed no association between muscle mass loss in mortality in the overall group, but did find a significant difference in mortality in 62 patients with stage III or IV disease.</p>
<p>Among 123 patients undergoing neoadjuvant chemoradiation,the loss of muscle mass during chemoradiation (as measured by skeletal muscle CSA) was predictive of postoperative mortality {Reisinger, #1993}. Muscle loss was 13.5% in patients with complication-related mortality, and 8% in those without.</p>
<p>Miyata H, Sugimura K, Motoori M, Fujiwara Y, Omori T, Yanagimoto Y, Ohue M, Yasui M, Miyoshi N, Tomokuni A, et al.&nbsp;Clinical assessment of sarcopenia and changes in body composition during neoadjuvant therapy for esophageal cancer <span class="citation" data-cites="miyata3053">(<a href="#ref-miyata3053" role="doc-biblioref">Miyata et al. 2017</a>)</span></p>
</section>
<section id="skeletal-muscle-loss-during-chemotherapy" class="level2">
<h2 class="anchored" data-anchor-id="skeletal-muscle-loss-during-chemotherapy">Skeletal muscle loss during chemotherapy</h2>
<p>Daly LE, Ni Bhuachalla EB, Power DG, Cushen SJ, James K, Ryan AM. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. J Cachexia Sarcopenia Muscle. 2018;9(2):315–25</p>
</section>
<section id="skeletal-muscle-loss-and-survival-after-esophagectomy" class="level2">
<h2 class="anchored" data-anchor-id="skeletal-muscle-loss-and-survival-after-esophagectomy">Skeletal muscle loss and survival after esophagectomy</h2>
<p>Among 130 Austrian patients, sarcopenia was noted in 80 (62%). Median survival was longer in patients without sarcopenia (52months) compared with those with sarcopenia (21 months).{Paireder, 2017 #2003}</p>
<p>Among 131 Korean patients undergoing esophagectomy for esophageal cancer, psoas muscle area was associated with survival.{Park, 2017,13}&nbsp; Among patients with higher psoas muscle area, 3-year survival was 64.9% and 37% in patients with lower psoas muscle area.</p>
<p>A Japanese study examined the predictive value of sarcopenia relative to anastomotic leak and overall survival after esophagectomy {Tamandl, 2016 #2006}. While sarcopenia in patients under age 65 was not associated with adverse outcomes, among 166 patients over age 65, sarcopenia was associated with decreased overall survival.</p>
<p>Among 98 Japanese patients undergoing esophagectomy for esophageal cancer, 31 (31%) were found to be sarcopenic. Among these patients.{Makiura, 2018 #2007} sarcopenia was associated with overall survival after adjusting for age, gender, and pathologic stage.</p>
<p>A meta-analysis of 4 studies totaling 649 patients showed that sarcopenia was associated with a survival hazard ratio of 1.5 compared with non-sarcopenia patients {Shachar, 2017 #2122}.</p>
<p>Patients undergoing transhiatal esophagectomy showed that among 230 patients, psoas muscle area was associated with post-operative survival among 64 patient who did not undergo neoadjuvant therapy, but was not a significant predictor on multivariable analysis among patients who received neoadjuvant therapy.{Sheetz, 2013 #1999}</p>
<p>Meta-analysis of 11 studies found that sarcopenia was associated with decreased survival after esophagectomy for esophageal cancer <span class="citation" data-cites="dengdoy115">(<a href="#ref-dengdoy115" role="doc-biblioref">Deng et al. 2019</a>)</span></p>
<p>Sarcopenia and survival and unplanned admissions after esophagectomy <span class="citation" data-cites="makiura456">(<a href="#ref-makiura456" role="doc-biblioref"><strong>makiura456?</strong></a>)</span></p>
<p>Sarcopenia and postop pulmonary complications after esophagectomy <span class="citation" data-cites="makiura430">(<a href="#ref-makiura430" role="doc-biblioref"><strong>makiura430?</strong></a>)</span></p>
</section>
</section>
<section id="risk-stratification-for-esophagectomy" class="level1">
<h1>Risk Stratification for esophagectomy</h1>
<section id="v02max" class="level2">
<h2 class="anchored" data-anchor-id="v02max">V02max</h2>
<p>Jack et al <span class="citation" data-cites="jack1313a">(<a href="#ref-jack1313a" role="doc-biblioref">Jack et al. 2014</a>)</span> studies VO2max before and after neoadjuvant chemoradiation prior to esophagectomy. Patients with lower baseline VO2max prior to surgery had lower 1-year survival after esophagectomy</p>



</section>
</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography">
<div id="ref-awad74" class="csl-entry" role="doc-biblioentry">
Awad, Sherif, Benjamin H. Tan, Helen Cui, Ashish Bhalla, Kenneth C. H. Fearon, Simon L. Parsons, James A. Catton, and Dileep N. Lobo. 2012. <span>“Marked Changes in Body Composition Following Neoadjuvant Chemotherapy for Oesophagogastric Cancer.”</span> <em>Clinical Nutrition (Edinburgh, Scotland)</em> 31 (1): 74–77. <a href="https://doi.org/10.1016/j.clnu.2011.08.008">https://doi.org/10.1016/j.clnu.2011.08.008</a>.
</div>
<div id="ref-dengdoy115" class="csl-entry" role="doc-biblioentry">
Deng, Han-Yu, Panpan Zha, Lei Peng, Liang Hou, Kai-Li Huang, and Xiao-Yun Li. 2019. <span>“Preoperative Sarcopenia Is a Predictor of Poor Prognosis of Esophageal Cancer After Esophagectomy: A Comprehensive Systematic Review and Meta-Analysis.”</span> <em>Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus</em> 32 (3): doy115. <a href="https://doi.org/10.1093/dote/doy115">https://doi.org/10.1093/dote/doy115</a>.
</div>
<div id="ref-elliott822" class="csl-entry" role="doc-biblioentry">
Elliott, Jessie A., Suzanne L. Doyle, Conor F. Murphy, Sinead King, Emer M. Guinan, Peter Beddy, Narayanasamy Ravi, and John V. Reynolds. 2017. <span>“Sarcopenia: <span>Prevalence</span>, and <span>Impact</span> on <span>Operative</span> and <span>Oncologic Outcomes</span> in the <span>Multimodal Management</span> of <span>Locally Advanced Esophageal Cancer</span>.”</span> <em>Annals of Surgery</em> 266 (5): 822–30. <a href="https://doi.org/10.1097/SLA.0000000000002398">https://doi.org/10.1097/SLA.0000000000002398</a>.
</div>
<div id="ref-jack1313a" class="csl-entry" role="doc-biblioentry">
Jack, S., M. A. West, D. Raw, S. Marwood, G. Ambler, T. M. Cope, M. Shrotri, et al. 2014. <span>“The Effect of Neoadjuvant Chemotherapy on Physical Fitness and Survival in Patients Undergoing Oesophagogastric Cancer Surgery.”</span> <em>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</em> 40 (10): 1313–20. <a href="https://doi.org/10.1016/j.ejso.2014.03.010">https://doi.org/10.1016/j.ejso.2014.03.010</a>.
</div>
<div id="ref-miyata3053" class="csl-entry" role="doc-biblioentry">
Miyata, Hiroshi, Keijiro Sugimura, Masaaki Motoori, Yoshiyuki Fujiwara, Takeshi Omori, Yoshitomo Yanagimoto, Masayuki Ohue, et al. 2017. <span>“Clinical <span>Assessment</span> of <span>Sarcopenia</span> and <span>Changes</span> in <span>Body Composition During Neoadjuvant Chemotherapy</span> for <span>Esophageal Cancer</span>.”</span> <em>Anticancer Research</em> 37 (6): 3053–59. <a href="https://doi.org/10.21873/anticanres.11660">https://doi.org/10.21873/anticanres.11660</a>.
</div>
<div id="ref-tamandl1359" class="csl-entry" role="doc-biblioentry">
Tamandl, Dietmar, Matthias Paireder, Reza Asari, Pascal A. Baltzer, Sebastian F. Schoppmann, and Ahmed Ba-Ssalamah. 2016. <span>“Markers of Sarcopenia Quantified by Computed Tomography Predict Adverse Long-Term Outcome in Patients with Resected Oesophageal or Gastro-Oesophageal Junction Cancer.”</span> <em>European Radiology</em> 26 (5): 1359–67. <a href="https://doi.org/10.1007/s00330-015-3963-1">https://doi.org/10.1007/s00330-015-3963-1</a>.
</div>
<div id="ref-tan333" class="csl-entry" role="doc-biblioentry">
Tan, B. H. L., K. Brammer, N. Randhawa, N. T. Welch, S. L. Parsons, E. J. James, and J. A. Catton. 2015. <span>“Sarcopenia Is Associated with Toxicity in Patients Undergoing Neo-Adjuvant Chemotherapy for Oesophago-Gastric Cancer.”</span> <em>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</em> 41 (3): 333–38. <a href="https://doi.org/10.1016/j.ejso.2014.11.040">https://doi.org/10.1016/j.ejso.2014.11.040</a>.
</div>
</div></section></div></main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
</div> <!-- /content -->



</body></html>